GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (BOM:541304) » Definitions » Asset Turnover

Indo US Bio-Tech (BOM:541304) Asset Turnover : 0.27 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Indo US Bio-Tech Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Indo US Bio-Tech's Revenue for the three months ended in Dec. 2024 was ₹235.6 Mil. Indo US Bio-Tech's Total Assets for the quarter that ended in Dec. 2024 was ₹878.4 Mil. Therefore, Indo US Bio-Tech's Asset Turnover for the quarter that ended in Dec. 2024 was 0.27.

Asset Turnover is linked to ROE % through Du Pont Formula. Indo US Bio-Tech's annualized ROE % for the quarter that ended in Dec. 2024 was 28.78%. It is also linked to ROA % through Du Pont Formula. Indo US Bio-Tech's annualized ROA % for the quarter that ended in Dec. 2024 was 23.02%.


Indo US Bio-Tech Asset Turnover Historical Data

The historical data trend for Indo US Bio-Tech's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Asset Turnover Chart

Indo US Bio-Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.36 1.02 1.01 1.24 1.47

Indo US Bio-Tech Quarterly Data
Mar17 Oct17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.28 0.28 0.31 0.27

Competitive Comparison of Indo US Bio-Tech's Asset Turnover

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech's Asset Turnover Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Asset Turnover falls into.


;
;

Indo US Bio-Tech Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Indo US Bio-Tech's Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=728.363/( (437.073+556.164)/ 2 )
=728.363/496.6185
=1.47

Indo US Bio-Tech's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=235.635/( (878.41+0)/ 1 )
=235.635/878.41
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Indo US Bio-Tech  (BOM:541304) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Indo US Bio-Tech's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=202.188/702.524
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(202.188 / 942.54)*(942.54 / 878.41)*(878.41/ 702.524)
=Net Margin %*Asset Turnover*Equity Multiplier
=21.45 %*1.073*1.2504
=ROA %*Equity Multiplier
=23.02 %*1.2504
=28.78 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Indo US Bio-Tech's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=202.188/878.41
=(Net Income / Revenue)*(Revenue / Total Assets)
=(202.188 / 942.54)*(942.54 / 878.41)
=Net Margin %*Asset Turnover
=21.45 %*1.073
=23.02 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Indo US Bio-Tech Asset Turnover Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo US Bio-Tech Business Description

Traded in Other Exchanges
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines